Will Moderna Soar on Nov. 6?
Key PointsInvestors are excited about Moderna’s personalized cancer vaccine candidate, which recently delivered positive clinical trial data.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.